Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Obese women with PCOS are more likely to have fatty liver disease.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Some men with early hair loss may have a condition similar to PCOS in women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.